Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
Allergy Therapeutics (AGY) Share Price & Analysis
9 Followers
AGY Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range1.06p - 6.30p
Previous Close4.8p
Volume619.35K
Average Volume (3M)873.40K
Market Cap
£228.79M
Enterprise Value249.93M
Total Cash (Recent Filing)£14.85M
Total Debt (Recent Filing)£35.99M
Price to Earnings (P/E)―
Beta0.61
Next Earnings
Sep 25, 2024EPS Estimate
-£0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding4,766,439,938
10 Day Avg. Volume183,019
30 Day Avg. Volume873,405
Standard Deviation0.16
R-Squared0.09
Alpha0.00375
Financial Highlights & Ratios
Price to Book (P/B)-8151.08
Price to Sales (P/S)1559.83
Price to Cash Flow (P/CF)-583.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Allergy Therapeutics News
PremiumCompany Announcements
Allergy Therapeutics Sees Financial and Clinical Progress
PremiumCompany Announcements
Allergy Therapeutics Appoints New Financial Adviser
PremiumCompany Announcements
Allergy Therapeutics Rolls Out New Incentive Plan
PremiumCompany Announcements
Allergy Therapeutics Welcomes New Board Member
PremiumCompany Announcements
Allergy Therapeutics VLP Peanut Vaccine Trial Advances
PremiumCompany Announcements
Allergy Therapeutics Nears Key Immunotherapy Submission
PremiumCompany Announcements
Allergy Therapeutics Showcases Advancements at EAACI 2024
PremiumCompany Announcements
Allergy Therapeutics Advances Grass Pollen ImmunotherapyOptions Prices
Currently, No data available
---
Ownership Overview
5.53% Insiders
0.00% Mutual Funds
0.12% Other Institutional Investors
94.36% Public Companies and
Individual Investors
AGY FAQ
What was Allergy Therapeutics PLC’s price range in the past 12 months?
Allergy Therapeutics PLC lowest share price was 1.06p and its highest was 6.30p in the past 12 months.
What is Allergy Therapeutics PLC’s market cap?
Currently, no data Available
When is Allergy Therapeutics PLC’s upcoming earnings report date?
Allergy Therapeutics PLC’s upcoming earnings report date is Sep 25, 2024 which is in 59 days.
How were Allergy Therapeutics PLC’s earnings last quarter?
Allergy Therapeutics PLC released its earnings results on Mar 27, 2024. The company reported -0.006p earnings per share for the quarter, missing the consensus estimate of N/A by -0.006p.
Is Allergy Therapeutics PLC overvalued?
According to Wall Street analysts Allergy Therapeutics PLC’s price is currently Overvalued.
Does Allergy Therapeutics PLC pay dividends?
Allergy Therapeutics PLC does not currently pay dividends.
What is Allergy Therapeutics PLC’s EPS estimate?
Allergy Therapeutics PLC’s EPS estimate is -£0.01.
How many shares outstanding does Allergy Therapeutics PLC have?
Allergy Therapeutics PLC has 4,766,440,000 shares outstanding.
What happened to Allergy Therapeutics PLC’s price movement after its last earnings report?
Allergy Therapeutics PLC reported an EPS of -0.006p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 11.111%.
Which hedge fund is a major shareholder of Allergy Therapeutics PLC?
Currently, no hedge funds are holding shares in GB:AGY
---
Allergy Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
353.68%
12-Months-Change
Fundamentals
Return on Equity
-155.90%
Trailing 12-Months
Asset Growth
-3.54%
Trailing 12-Months
Company Description
Allergy Therapeutics PLC
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.
---
Technical Analysis
---